ADCD assay.

CA Caroline Atyeo
MS Matthew D. Slein
SF Stephanie Fischinger
JB John Burke
AS Alexandra Schäfer
SL Sarah R. Leist
NK Natalia A. Kuzmina
CM Chad Mire
AH Anna Honko
RJ Rebecca Johnson
NS Nadia Storm
MB Matthew Bernett
PT Pei Tong
TZ Teng Zuo
JL Junrui Lin
AZ Adam Zuiani
CL Caitlyn Linde
TS Todd Suscovich
DW Duane R. Wesemann
AG Anthony Griffiths
JD John R. Desjarlais
BJ Boris D. Juelg
JG Jaap Goudsmit
AB Alexander Bukreyev
RB Ralph Baric
GA Galit Alter
ask Ask a question
Favorite

The ADCD assay was adapted from Fischinger et al. (57). Antigen was coupled to red fluorescent Neutravidin 1 μm beads (Invitrogen, Thermo Fisher Scientific, F8775) as described for ADCP. Immune complexes were formed by incubating 10 μL of coupled beads with 50 μL of antibody at concentrations of 50 μg/mL, 10 μg/mL, 2 μg/mL, and 0.4 μg/mL for 2 hours at 37°C. Plated were spun down, and immune complexes were washed with PBS. Lyophilized guinea pig complement (Cedarlane, CL4051) was resuspended in 1 mL of cold water, diluted 1:50 in GVB++ (gelatin veronal buffer and additional Ca2+ and Mg2+, Boston BioProducts, IBB-300X), and added to the immune complexes. The plates were incubated for 20 minutes at 37°C, and the reaction was stopped by washing the plates twice with 15 mM EDTA in PBS. To detect complement deposition, plates were incubated with fluorescein-conjugated goat anti–guinea pig complement C3 (MP Biomedicals, 0855385) for 15 minutes in the dark. Fluorescence was acquired with an Intellicyt iQue.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A